| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | CLP 4.66T | CLP 4.90T | CLP 5.22T | CLP 4.72T | CLP 3.37T |
| Gross Profit | CLP 2.28T | CLP 2.09T | CLP 1.59T | CLP 1.85T | CLP 1.97T |
| Operating Income | CLP 1.25T | CLP 1.08T | CLP 691.38B | CLP 901.11B | CLP 1.07T |
| EBITDA | CLP 1.38T | CLP 1.22T | CLP 835.15B | CLP 1.03T | CLP 1.20T |
| Net Income | CLP 1.02T | CLP 852.96B | CLP 579.43B | CLP 792.28B | CLP 842.47B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | CLP 6.64T | CLP 7.61T | CLP 10.52T | CLP 11.30T | CLP 11.14T |
| Total Assets | CLP 68.15T | CLP 68.40T | CLP 71.09T | CLP 68.42T | CLP 63.84T |
| Total Debt | CLP 15.88T | CLP 14.73T | CLP 12.71T | CLP 10.90T | CLP 10.38T |
| Net Debt | CLP 10.64T | CLP 9.61T | CLP 6.93T | CLP 5.63T | CLP 5.12T |
| Total Liabilities | CLP 62.41T | CLP 63.04T | CLP 65.77T | CLP 63.46T | CLP 59.41T |
| Stockholders' Equity | CLP 5.62T | CLP 5.25T | CLP 5.19T | CLP 4.85T | CLP 4.33T |
| Cash Flow | |||||
| Free Cash Flow | CLP 624.40B | CLP 374.67B | CLP -2.22T | CLP -472.28B | CLP -3.24T |
| Operating Cash Flow | CLP 704.90B | CLP 482.39B | CLP -2.17T | CLP -358.99B | CLP -3.19T |
| Investing Cash Flow | CLP -1.29T | CLP -106.58B | CLP -100.08B | CLP -94.60B | CLP -84.27B |
| Financing Cash Flow | CLP -50.06B | CLP -372.85B | CLP 2.95T | CLP -384.32B | CLP 2.83T |